Concepedia

Csaba Bajusz

CB

Statistics

Publications

7

Citations

538

H-Index

7

Active since

2017

Affiliations

HUN-REN Szegedi Biológiai Kutatóközpont(Current)

University of Pennsylvania

Institute of Genetics

University of Szeged

Acuitas Therapeutics (Canada)

Csaba Bajusz is an author at HUN-REN Szegedi Biológiai Kutatóközpont specializing in molecular biology, nanoparticle vaccine platforms, and nucleic acid vaccines.

Publications per year

2017–2024

7

Publications

7

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine

Hiromi Muramatsu, Kieu Lam, Csaba Bajusz et al. · Molecular Therapy · 2022 · 310 citations · Full text

, , +17

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Norbert Pardi, Juan Manuel Carreño, George O’Dell et al. · Nature Communications · 2022 · 85 citations · Full text

, , +17

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

Meagan McMahon, George O’Dell, Jessica Tan et al. · Proceedings of the National Academy of Sciences · 2022 · 82 citations · Full text

, , +17

Drosophila Atg9 regulates the actin cytoskeleton via interactions with profilin and Ena

Viktória Kiss, András Jipa, Kata Varga et al. · Cell Death and Differentiation · 2019 · 23 citations

, , +14

The actin binding cytoskeletal protein Moesin is involved in nuclear mRNA export

Ildikó Kristó, Csaba Bajusz, Barbara N. Borsos et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2017 · 16 citations

, , +12

1–5 of 7